The Impact of New Cardiovascular Device Technology on Health Care Costs
Open Access
- 25 July 2011
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 171 (14) , 1289-1291
Abstract
Drug-eluting coronary stents (DESs) are widely used1 and entail sizeable Medicare hospital expenditures.2 However, the overall cost impact of DESs has not been well quantified. A clear understanding of how new technologies like DESs affect health care expenditures can provide insight into national trends in health care cost growth, of which new technology is presumably the leading driver.3 New technology may not only increase costs by being more expensive than previous treatments, but also by changing the patterns of care for chronic disease.4 Accordingly, we sought to assess the overall impact of DESs on Medicare expenditures in a nationally representative cohort of Medicare beneficiaries with coronary artery disease (CAD).Keywords
This publication has 8 references indexed in Scilit:
- 2006 National Hospital Discharge Survey.2008
- Faculty Opinions recommendation of Optimal medical therapy with or without PCI for stable coronary disease.2007
- Optimal Medical Therapy with or without PCI for Stable Coronary DiseaseNew England Journal of Medicine, 2007
- Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery DiseaseCirculation, 2005
- Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary StenosesCirculation, 2004
- Racial Disparity in Cardiac Procedures and Mortality Among Long-Term Survivors of Cardiac ArrestCirculation, 2003
- Diffusion of Laparoscopic Cholecystectomy Among General Surgeons in the United StatesMedical Care, 1995
- Medical Care Costs: How Much Welfare Loss?Journal of Economic Perspectives, 1992